Howard Hughes Medical Institute Has Cut Deere & Co (DE) Stake; Cormorant Asset Management Trimmed Its Bluebird Bio (BLUE) Stake

February 18, 2018 - By Nellie Frank

Cormorant Asset Management Llc decreased Bluebird Bio Inc (BLUE) stake by 50% reported in 2017Q3 SEC filing. Cormorant Asset Management Llc sold 137,500 shares as Bluebird Bio Inc (BLUE)’s stock rose 6.94%. The Cormorant Asset Management Llc holds 137,500 shares with $18.89M value, down from 275,000 last quarter. Bluebird Bio Inc now has $10.54 billion valuation. The stock increased 2.25% or $4.7 during the last trading session, reaching $213.35. About 645,814 shares traded. bluebird bio, Inc. (NASDAQ:BLUE) has risen 112.34% since February 18, 2017 and is uptrending. It has outperformed by 95.64% the S&P500.

Howard Hughes Medical Institute decreased Deere & Co (DE) stake by 49.44% reported in 2017Q3 SEC filing. Howard Hughes Medical Institute sold 34,220 shares as Deere & Co (DE)’s stock rose 9.64%. The Howard Hughes Medical Institute holds 35,000 shares with $4.40 million value, down from 69,220 last quarter. Deere & Co now has $54.77 billion valuation. The stock increased 1.58% or $2.63 during the last trading session, reaching $169.44. About 6.63M shares traded or 173.14% up from the average. Deere & Company (NYSE:DE) has risen 46.99% since February 18, 2017 and is uptrending. It has outperformed by 30.29% the S&P500.

Analysts await bluebird bio, Inc. (NASDAQ:BLUE) to report earnings on February, 28. They expect $-1.63 EPS, up 13.30% or $0.25 from last year’s $-1.88 per share. After $-1.73 actual EPS reported by bluebird bio, Inc. for the previous quarter, Wall Street now forecasts -5.78% EPS growth.

Among 25 analysts covering bluebird bio (NASDAQ:BLUE), 14 have Buy rating, 2 Sell and 9 Hold. Therefore 56% are positive. bluebird bio had 81 analyst reports since August 11, 2015 according to SRatingsIntel. The stock has “Buy” rating by Canaccord Genuity on Thursday, February 1. Morgan Stanley maintained the stock with “Hold” rating in Wednesday, June 14 report. The stock of bluebird bio, Inc. (NASDAQ:BLUE) earned “Buy” rating by SunTrust on Friday, November 3. The stock has “Neutral” rating by TH Capital on Monday, February 6. As per Friday, August 28, the company rating was maintained by Roth Capital. Cantor Fitzgerald maintained bluebird bio, Inc. (NASDAQ:BLUE) rating on Monday, July 24. Cantor Fitzgerald has “Sell” rating and $3900 target. JP Morgan maintained the shares of BLUE in report on Saturday, August 22 with “Overweight” rating. The company was downgraded on Monday, February 6 by Roth Capital. On Friday, November 3 the stock rating was upgraded by Morgan Stanley to “Equal-Weight”. The firm has “Buy” rating given on Thursday, November 5 by TH Capital.

Investors sentiment increased to 1.79 in Q3 2017. Its up 0.11, from 1.68 in 2017Q2. It is positive, as 35 investors sold BLUE shares while 42 reduced holdings. 45 funds opened positions while 93 raised stakes. 49.05 million shares or 2.37% more from 47.91 million shares in 2017Q2 were reported. Federated Invsts Pa accumulated 18,371 shares. Illinois-based Northern has invested 0.02% in bluebird bio, Inc. (NASDAQ:BLUE). Tiverton Asset Ltd Liability Corp holds 0.22% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE) for 27,766 shares. 2,202 were accumulated by Raymond James Fincl Advsrs. Eam Lc accumulated 18,311 shares. Commerzbank Aktiengesellschaft Fi has 0.02% invested in bluebird bio, Inc. (NASDAQ:BLUE). Next Fin Grp Inc accumulated 0% or 16 shares. Sivik Ltd holds 0.82% or 17,500 shares. Bnp Paribas Arbitrage Sa invested in 5,444 shares or 0% of the stock. Columbus Circle Invsts accumulated 139,312 shares. Public Employees Retirement System Of Ohio invested 0.01% in bluebird bio, Inc. (NASDAQ:BLUE). 173,540 are owned by Mitsubishi Ufj Trust Corporation. Jpmorgan Chase invested in 0% or 53,636 shares. Artal Grp Inc has 135,000 shares. C Worldwide A S accumulated 2,474 shares.

Investors sentiment decreased to 0.93 in Q3 2017. Its down 0.07, from 1 in 2017Q2. It worsened, as 64 investors sold DE shares while 312 reduced holdings. 69 funds opened positions while 281 raised stakes. 213.38 million shares or 1.82% more from 209.56 million shares in 2017Q2 were reported. Calamos owns 66,608 shares. Highlander Mngmt Limited Liability holds 200 shares. 2,460 were accumulated by Colony Ltd Liability. Twin Capital Mngmt accumulated 63,040 shares or 0.42% of the stock. 5,142 were accumulated by Sterling Cap Mngmt Limited Liability Corp. Diamond Hill reported 342,689 shares or 0.23% of all its holdings. Moreover, Sei Invs Company has 0.1% invested in Deere & Company (NYSE:DE). Lombard Odier Asset (Europe) Limited invested 0.03% of its portfolio in Deere & Company (NYSE:DE). Estabrook Capital owns 3,216 shares. Mitchell Mcleod Pugh And Williams accumulated 4,385 shares or 0.41% of the stock. Of Vermont has 0.08% invested in Deere & Company (NYSE:DE) for 6,688 shares. Sector Pension Investment Board accumulated 32,689 shares. Meristem Llp invested in 1.08% or 21,412 shares. Barrett Asset Mgmt Limited Liability Company invested in 0.01% or 600 shares. Generation Investment Ltd Liability Partnership holds 3.13 million shares.

Since August 22, 2017, it had 0 buys, and 9 selling transactions for $20.31 million activity. The insider von Pentz Markwart sold 46,457 shares worth $5.42 million. May John C II sold $1.40M worth of stock. Another trade for 22,095 shares valued at $3.76M was made by Field James M. on Friday, January 12. Guinn Max A sold $1.90 million worth of stock or 11,235 shares. Reed Cory J also sold $972,253 worth of Deere & Company (NYSE:DE) on Monday, December 11. The insider Jones Mary K.W. sold $1.69 million.

Among 29 analysts covering Deere & Company (NYSE:DE), 13 have Buy rating, 3 Sell and 13 Hold. Therefore 45% are positive. Deere & Company had 119 analyst reports since July 27, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, December 12 by Barclays Capital. The rating was maintained by Barclays Capital with “Underweight” on Monday, October 26. The rating was maintained by Piper Jaffray on Monday, May 23 with “Neutral”. The company was maintained on Friday, August 25 by Piper Jaffray. The stock has “Buy” rating by Robert W. Baird on Tuesday, November 21. The firm has “Hold” rating by RBC Capital Markets given on Friday, March 24. Piper Jaffray maintained the stock with “Hold” rating in Monday, November 27 report. J.P. Morgan upgraded Deere & Company (NYSE:DE) rating on Friday, June 2. J.P. Morgan has “Hold” rating and $12200 target. The firm has “Sell” rating given on Wednesday, August 19 by William Blair. The stock of Deere & Company (NYSE:DE) has “Underweight” rating given on Friday, September 25 by Barclays Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: